可编程鞘内输注系统治疗慢性疼痛：提高效率的建议。
Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiency.
机构信息
Department of Anesthesiology and Pain Medicine, University of Texas Medical Branch, Galveston, TX, USA.
出版信息
J Pain Res. 2014 Oct 3;7:571-7. doi: 10.2147/JPR.S46929. eCollection 2014.
Abstract
The management of chronic pain can be very challenging. Often, physicians employ intrathecal (IT) drug delivery systems as a last resort to relieve intractable pain. The system consists of an implantable pump that stores and delivers medication through a catheter to the IT space. Programmability is achieved by positioning an external devise over the implanted pump to change the mode of drug delivery. The innovations in programmable IT drug delivery systems are expanding more rapidly than ever before. Unfortunately, the rapid expansion is accompanied by a lack of prospective randomized trials examining these new options. In an effort to improve results and reduce side effects, publications by experts or expert consensus panels provide guidance for the community. The purpose of this article is to provide a summary of high interest topics in recent publications.
摘要
慢性疼痛的管理极具挑战性。通常，医生会将鞘内（IT）药物输送系统作为缓解难治性疼痛的最后手段。该系统包括一个可植入的泵，通过导管将药物储存在其中并输送到 IT 空间。通过将外部设备放置在植入式泵上来改变药物输送模式，从而实现可编程性。可编程 IT 药物输送系统的创新比以往任何时候都发展得更快。不幸的是，快速扩张伴随着缺乏前瞻性随机试验来检查这些新选择。为了提高疗效和减少副作用，专家或专家共识小组的出版物为社区提供了指导。本文的目的是总结近期出版物中一些热门话题。
相似文献
1
Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiency.可编程鞘内输注系统治疗慢性疼痛：提高效率的建议。
J Pain Res. 2014 Oct 3;7:571-7. doi: 10.2147/JPR.S46929. eCollection 2014.
2
Intrathecal opioids for intractable pain syndromes.用于顽固性疼痛综合征的鞘内注射阿片类药物。
Acta Neurochir Suppl. 2007;97(Pt 1):43-8. doi: 10.1007/978-3-211-33079-1_5.
3
Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.鞘内持续注射吗啡治疗非恶性病因慢性疼痛：长期益处和疗效
Surg Neurol. 2001 Feb;55(2):79-86; discussion 86-8. doi: 10.1016/s0090-3019(01)00353-6.
4
Intrathecal drug therapy for long-term pain management.鞘内药物治疗用于长期疼痛管理。
Am J Health Syst Pharm. 2007 Dec 1;64(23):2447-61. doi: 10.2146/ajhp060204.
5
Intrathecal administration of Infumorph® vs compounded morphine for treatment of intractable pain using the Prometra® programmable pump.鞘内给予 Infumorph®与使用 Prometra®可编程输注系统进行复配吗啡治疗难治性疼痛的比较。
Pain Med. 2013 Jun;14(6):865-73. doi: 10.1111/pme.12077. Epub 2013 Apr 9.
6
Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps.慢性疼痛患者的患者自控镇痛：使用一种设计用于与植入式可编程泵配合使用的新设备的经验。
Pain Pract. 2008 May-Jun;8(3):164-70. doi: 10.1111/j.1533-2500.2008.00187.x. Epub 2008 Mar 31.
7
Management of patients with pain and severe side effects while on intrathecal morphine therapy: A case study.鞘内注射吗啡治疗期间疼痛及严重副作用患者的管理：一项病例研究。
Scand J Pain. 2017 Oct;17:37-40. doi: 10.1016/j.sjpain.2017.07.006. Epub 2017 Jul 27.
8
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.多模式镇痛共识会议（PACC）：关于鞘内药物输注系统最佳实践和指南的建议。
Neuromodulation. 2017 Feb;20(2):96-132. doi: 10.1111/ner.12538. Epub 2017 Jan 2.
9
Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.鞘内药物输注系统治疗难治性癌痛患者的疗效：单中心经验。
J Formos Med Assoc. 2012 May;111(5):253-7. doi: 10.1016/j.jfma.2011.03.005. Epub 2012 Mar 11.
10
Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.《癌症疼痛治疗鞘内药物输注治疗系统的综合共识指南》。
Pain Physician. 2011 May-Jun;14(3):E283-312.
引用本文的文献
1
The Impact of Radiation Therapy on Intrathecal Drug Delivery System Functioning and Safety.放射治疗对鞘内给药系统功能及安全性的影响。
Curr Pain Headache Rep. 2025 Mar 14;29(1):60. doi: 10.1007/s11916-025-01375-2.
2
Intrathecal Fentanyl Pump Placement in a Patient With Chronic Pain Caused by Hereditary Multiple Exostoses: A Case Report.鞘内注射芬太尼泵植入治疗遗传性多发性骨软骨瘤所致慢性疼痛1例报告
Cureus. 2024 Nov 7;16(11):e73240. doi: 10.7759/cureus.73240. eCollection 2024 Nov.
3
A comprehensive review on ziconotide.关于齐考诺肽的全面综述。
Heliyon. 2024 May 11;10(10):e31105. doi: 10.1016/j.heliyon.2024.e31105. eCollection 2024 May 30.
4
Safety and Efficacy of Surgical Implantation of Intrathecal Drug Delivery Pumps in Patients With Cancer With Refractory Pain.鞘内药物输注泵手术植入在难治性疼痛癌症患者中的安全性和有效性
Neurosurgery. 2024 Nov 1;95(5):1072-1081. doi: 10.1227/neu.0000000000002978. Epub 2024 May 3.
5
Case Report: An Unexpected Complication of Intrathecal Therapy.病例报告：鞘内治疗的意外并发症。
A A Pract. 2024 Apr 8;18(4):e01774. doi: 10.1213/XAA.0000000000001774. eCollection 2024 Apr 1.
6
Answering Big Questions in Pain Medicine.解答疼痛医学中的重大问题。
Cureus. 2023 Aug 16;15(8):e43561. doi: 10.7759/cureus.43561. eCollection 2023 Aug.
7
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.鞘内药物递送：慢性疼痛患者管理中的进展与应用
Front Pain Res (Lausanne). 2022 Jun 16;3:900566. doi: 10.3389/fpain.2022.900566. eCollection 2022.
8
The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.美国疼痛与神经科学学会（ASPN）癌症相关疼痛介入管理的最佳实践与指南。
J Pain Res. 2021 Jul 16;14:2139-2164. doi: 10.2147/JPR.S315585. eCollection 2021.
9
Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications.鞘内药物递送（IDD）的叙述性综述：适应症、装置及潜在并发症
Ann Transl Med. 2021 Jan;9(2):186. doi: 10.21037/atm-20-3814.
10
Advanced implantable drug delivery technologies: transforming the clinical landscape of therapeutics for chronic diseases.先进的植入式药物输送技术：改变慢性疾病治疗的临床格局。
Biomed Microdevices. 2019 May 18;21(2):47. doi: 10.1007/s10544-019-0389-6.
本文引用的文献
1
High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery.术前糖化血红蛋白水平高是胸腰椎后路脊柱内固定手术后手术部位感染的一个危险因素。
J Orthop Sci. 2014 Mar;19(2):223-228. doi: 10.1007/s00776-013-0518-7. Epub 2013 Dec 25.
2
Intrathecal therapy for chronic pain: current trends and future needs.鞘内治疗慢性疼痛：当前趋势和未来需求。
Curr Pain Headache Rep. 2014 Jan;18(1):388. doi: 10.1007/s11916-013-0388-x.
3
4
Intrathecal infusion systems for long-term management of chronic non-cancer pain: an update of assessment of evidence.鞘内输注系统用于慢性非癌性疼痛的长期管理：证据评估的更新。
Pain Physician. 2013 Apr;16(2 Suppl):SE185-216.
5
An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.慢性脊柱疼痛介入技术的综合循证指南更新。第二部分：指导和建议。
Pain Physician. 2013 Apr;16(2 Suppl):S49-283.
6
Implant contamination during spine surgery.脊柱手术中的植入物污染。
Spine J. 2013 Jun;13(6):637-40. doi: 10.1016/j.spinee.2012.11.053. Epub 2013 Jan 12.
7
Polyanalgesic Consensus Conference 2012.2012年多模式镇痛共识会议
Neuromodulation. 2012 Sep-Oct;15(5):418-9. doi: 10.1111/j.1525-1403.2012.00507.x.
8
Polyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain.多模式镇痛共识会议——2012：降低鞘内药物输注治疗慢性疼痛的发病率和死亡率的建议。
Neuromodulation. 2012 Sep-Oct;15(5):467-82; discussion 482. doi: 10.1111/j.1525-1403.2012.00486.x. Epub 2012 Jul 31.
9
Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.前瞻性研究：低剂量鞘内阿片类药物治疗慢性非恶性疼痛的 3 年随访。
Pain Med. 2012 Oct;13(10):1304-13. doi: 10.1111/j.1526-4637.2012.01451.x. Epub 2012 Jul 30.
10
Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.多模式镇痛共识会议 2012：鞘内（椎管内）药物输送治疗疼痛管理的推荐意见：跨学科专家小组的报告。
Neuromodulation. 2012 Sep-Oct;15(5):436-64; discussion 464-6. doi: 10.1111/j.1525-1403.2012.00476.x. Epub 2012 Jul 2.
Zotero 插件